A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression. — CFSMEATLAS
A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression.
Kendler, Kenneth S, Rosmalen, Judith G M, Ohlsson, Henrik et al. · Psychological medicine · 2023 · DOI
Quick Summary
This study looked at the family histories of over 5 million Swedish people to understand whether ME/CFS, fibromyalgia, and irritable bowel syndrome share common genetic roots. Researchers found that people with these conditions have a distinctive pattern of genetic risk that affects multiple body systems—including pain, mood, immune function, and sleep—rather than being limited to one specific area like depression or rheumatoid arthritis. This suggests these functional somatic disorders may arise from a complex genetic vulnerability affecting several interconnected systems rather than a single cause.
Why It Matters
This study provides genetic evidence that ME/CFS shares a complex, multi-system etiology distinct from single-system disorders, validating patient experiences of multi-system involvement. Understanding this distinctive genetic pattern may help clinicians recognize ME/CFS as a condition with biological underpinnings spanning multiple physiological systems, potentially reducing diagnostic delays and stigma. For researchers, it suggests future investigations should examine interactions between genetic vulnerabilities affecting pain, immune, sleep, and neuropsychiatric systems rather than pursuing single-pathway models.
Observed Findings
FM cases showed substantial genetic risk not only for FM but also for pain syndromes, internalizing disorders, autoimmune conditions, and sleep disorders.
IBS and CFS cases demonstrated widely distributed genetic risk patterns, though with lower average magnitude compared to FM.
Major depression and rheumatoid arthritis exhibited much more restricted genetic risk profiles limited to conditions closely related to each disorder.
The genetic risk profile for FM differed markedly from both a prototypic autoimmune disorder (RA) and internalizing psychiatric disorder (MD).
A less pronounced but similar pattern of broad genetic risk across multiple disorder types was observed in IBS and CFS.
Inferred Conclusions
Functional somatic disorders arise from a distinctive pattern of genetic liability affecting multiple systems (psychiatric, autoimmune, pain, sleep, somatic) rather than being restricted to single domains.
The genetic architecture of FSDs is qualitatively different from both classic autoimmune disorders and primary internalizing psychiatric disorders.
The breadth of genetic risk for FM, IBS, and CFS suggests these conditions may share underlying biological mechanisms spanning pain processing, immune regulation, mood, and sleep homeostasis.
Remaining Questions
Which specific genetic variants and biological pathways account for the observed multi-system genetic risk in ME/CFS, and how do they interact?
What This Study Does Not Prove
This study does not prove that genes alone cause ME/CFS—family aggregation reflects both shared genes and potentially shared environmental factors, which the methodology could not entirely separate. It does not identify specific genes responsible for ME/CFS or clarify whether the genetic overlap reflects true biological pathways or diagnostic overlap in ascertainment. The findings are correlational and cannot establish causal mechanisms underlying the observed genetic risk patterns.